Edwards Lifesciences Shares Up 19.1% as Earnings Yield Tops Industry at 3.6%
Edwards Lifesciences carries a Zacks Rank #2 with a 3.6% earnings yield, outperforming the industry’s negative 0.7% yield, as its shares have climbed 19.1% over the past year. The company beat earnings estimates in three of the trailing four quarters with an average surprise of 5.5%.
1. Strong Share Performance
Edwards Lifesciences shares have risen 19.1% over the past year, outpacing the industry’s 4.3% decline and reflecting strong market sentiment. This rally indicates investor confidence in the company’s operational consistency and market positioning.
2. Earnings Yield and Surprises
The company holds a Zacks Rank #2 with an earnings yield of 3.6%, well above the industry’s negative 0.7%. Edwards beat consensus estimates in three of the last four quarters, delivering an average surprise of 5.5% and highlighting its financial resilience.